Cocrystal Pharma, Inc. (COCP)
1.135
+0.02
(+2.25%)
USD |
NASDAQ |
Aug 25, 16:00
1.135
0.00 (0.00%)
After-Hours: 19:59
Cocrystal Pharma Shareholders Equity (Quarterly) : 1.044M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.044M |
| March 31, 2026 | 4.116M |
| December 31, 2025 | 6.331M |
| September 30, 2025 | 7.669M |
| June 30, 2025 | 5.333M |
| March 31, 2025 | 7.304M |
| December 31, 2024 | 9.523M |
| September 30, 2024 | 12.70M |
| June 30, 2024 | 17.39M |
| March 31, 2024 | 22.58M |
| December 31, 2023 | 26.38M |
| September 30, 2023 | 30.69M |
| June 30, 2023 | 34.68M |
| March 31, 2023 | 34.67M |
| December 31, 2022 | 39.57M |
| September 30, 2022 | 43.91M |
| June 30, 2022 | 49.39M |
| March 31, 2022 | 73.58M |
| December 31, 2021 | 77.55M |
| September 30, 2021 | 81.01M |
| June 30, 2021 | 84.75M |
| March 31, 2021 | 52.06M |
| December 31, 2020 | 52.50M |
| September 30, 2020 | 50.18M |
| June 30, 2020 | 37.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 40.43M |
| December 31, 2019 | 25.71M |
| September 30, 2019 | 70.74M |
| June 30, 2019 | 72.42M |
| March 31, 2019 | 73.82M |
| December 31, 2018 | 66.89M |
| September 30, 2018 | 110.90M |
| June 30, 2018 | 112.65M |
| March 31, 2018 | 104.14M |
| December 31, 2017 | 105.40M |
| September 30, 2017 | 100.00M |
| June 30, 2017 | 102.04M |
| March 31, 2017 | 99.98M |
| December 31, 2016 | 102.32M |
| September 30, 2016 | 167.82M |
| June 30, 2016 | 166.83M |
| March 31, 2016 | 169.34M |
| December 31, 2015 | 167.59M |
| September 30, 2015 | 196.75M |
| June 30, 2015 | 196.52M |
| March 31, 2015 | 188.70M |
| December 31, 2014 | 184.87M |
| September 30, 2014 | 3.978M |
| June 30, 2014 | 6.056M |
| March 31, 2014 | -2.074M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
| Definium Therapeutics, Inc. | 918.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.649M |
| Total Liabilities (Quarterly) | 3.605M |
| Debt to Equity Ratio | 1.284 |
| Current Ratio | 1.237 |
| Net Debt Paydown Yield | 0.54% |